EGF Theramed Health Corp. (EVAHF)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -567.35 Thousand CAD | 42.67% |
| 2022 | -989.65 Thousand CAD | 18.15% |
| 2021 | -1.2 Million CAD | 50.78% |
| 2020 | -2.45 Million CAD | 12.09% |
| 2019 | -2.79 Million CAD | -214.24% |
| 2018 | -889.33 Thousand CAD | 29.6% |
| 2017 | -1.26 Million CAD | -509.24% |
| 2016 | -207.34 Thousand CAD | 48.79% |
| 2015 | -404.87 Thousand CAD | -1381.9% |
| 2014 | -27.32 Thousand CAD | 91.95% |
| 2013 | -339.54 Thousand CAD | -11091.33% |
| 2012 | -3034.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -48.49 Thousand CAD | 0.0% |
| 2024 Q3 | -49.61 Thousand CAD | -7.67% |
| 2024 Q2 | -56.2 Thousand CAD | -15.9% |
| 2023 Q3 | -72.52 Thousand CAD | 40.62% |
| 2023 FY | - CAD | 42.67% |
| 2023 Q4 | -113.23 Thousand CAD | -56.12% |
| 2023 Q1 | -260.28 Thousand CAD | -97.88% |
| 2023 Q2 | -122.14 Thousand CAD | 53.07% |
| 2022 Q4 | -131.53 Thousand CAD | 77.45% |
| 2022 FY | - CAD | 18.15% |
| 2022 Q1 | -156.62 Thousand CAD | 73.32% |
| 2022 Q2 | -118.07 Thousand CAD | 24.61% |
| 2022 Q3 | -583.42 Thousand CAD | -394.11% |
| 2021 Q2 | -245.07 Thousand CAD | -11.46% |
| 2021 Q1 | -219.87 Thousand CAD | 86.63% |
| 2021 FY | - CAD | 50.78% |
| 2021 Q3 | -157.17 Thousand CAD | 35.86% |
| 2021 Q4 | -586.98 Thousand CAD | -273.45% |
| 2020 Q2 | -287.4 Thousand CAD | 19.69% |
| 2020 Q4 | -1.64 Million CAD | -379.87% |
| 2020 Q1 | -357.87 Thousand CAD | 61.77% |
| 2020 FY | - CAD | 12.09% |
| 2020 Q3 | -342.61 Thousand CAD | -19.21% |
| 2019 Q2 | -509.86 Thousand CAD | 24.44% |
| 2019 FY | - CAD | -214.24% |
| 2019 Q4 | -936.18 Thousand CAD | -36.32% |
| 2019 Q3 | -686.77 Thousand CAD | -34.7% |
| 2019 Q1 | -674.78 Thousand CAD | -246.27% |
| 2018 Q1 | -81.16 Thousand CAD | 79.59% |
| 2018 Q2 | -70.37 Thousand CAD | 13.29% |
| 2018 Q3 | -170.6 Thousand CAD | -142.44% |
| 2018 FY | - CAD | 29.6% |
| 2018 Q4 | 461.31 Thousand CAD | 370.4% |
| 2017 Q2 | -12.41 Thousand CAD | 30.62% |
| 2017 Q4 | -397.73 Thousand CAD | 53.01% |
| 2017 Q3 | -846.43 Thousand CAD | -6718.41% |
| 2017 FY | - CAD | -509.24% |
| 2017 Q1 | -17.89 Thousand CAD | 86.16% |
| 2016 Q1 | -11.95 Thousand CAD | 91.81% |
| 2016 FY | - CAD | 48.79% |
| 2016 Q4 | -129.33 Thousand CAD | -345.98% |
| 2016 Q3 | -29 Thousand CAD | -0.85% |
| 2016 Q2 | -28.75 Thousand CAD | -140.49% |
| 2015 Q1 | -67.47 Thousand CAD | -318.57% |
| 2015 Q4 | -146.07 Thousand CAD | -151.71% |
| 2015 Q2 | -16.87 Thousand CAD | 74.99% |
| 2015 FY | - CAD | -1381.9% |
| 2015 Q3 | -58.03 Thousand CAD | -243.84% |
| 2014 Q4 | 30.87 Thousand CAD | 340.53% |
| 2014 Q2 | -12.69 Thousand CAD | 61.12% |
| 2014 Q1 | -32.65 Thousand CAD | 90.14% |
| 2014 Q3 | -12.83 Thousand CAD | -1.06% |
| 2014 FY | - CAD | 91.95% |
| 2013 FY | - CAD | -11091.33% |
| 2013 Q3 | -6.00 CAD | 0.0% |
| 2013 Q4 | -331.29 Thousand CAD | -5521483.33% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 93.186% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -2.84 Million USD | 80.067% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 49.095% |
| CompuMed, Inc. | 690.19 Thousand USD | 182.202% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.267% |
| Cogstate Limited | 9.89 Million USD | 105.736% |
| CareView Communications, Inc. | -210.04 Thousand USD | -170.114% |
| Craneware plc | 54.26 Million USD | 101.046% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 95.385% |
| Certive Solutions Inc. | -704.66 Thousand USD | 19.486% |
| Drug Free Solution, Inc. | -1.39 Million USD | 59.328% |
| DATATRAK International, Inc. | 2.72 Million USD | 120.793% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -764.731% |
| Healixa Inc. | -6.32 Million USD | 91.023% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 105.579% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -33.341% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| iCoreConnect Inc. | -11.87 Million USD | 95.224% |
| IQ-AI Limited | -370.35 Thousand USD | -53.192% |
| Cannabiz Mobile, Inc. | -750.00 USD | -75546.667% |
| Mednow Inc. | -28.12 Million USD | 97.983% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -109.568% |
| MediXall Group, Inc. | -6.52 Million USD | 91.303% |
| Mitesco, Inc. | -11.96 Million USD | 95.258% |
| MobileSmith, Inc. | -13.83 Million USD | 95.9% |
| NantHealth, Inc. | -38.53 Million USD | 98.528% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 66.587% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 95.306% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 95.311% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 143.252% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 859.2% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -4556.517% |
| Renalytix Plc | -28.52 Million USD | 98.011% |
| Revium Recovery Inc. | -678 Thousand USD | 16.32% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -153653.388% |
| Vaso Corporation | 4.19 Million USD | 113.524% |
| Vynleads, Inc. | -235.72 Thousand USD | -140.682% |